Court of Common Pleas Leaves Standing Janssen’s Victory in Second Risperdal Trial [Drug and Device Law]

John Sullivan, a member of Cozen O’Connor’s Commercial Litigation Department, discusses the second Risperdal trial, Cirba v. Janssen Pharmaceuticals, Inc., in which the trial judge denied the plaintiff’s post-trial motion for a new trial. The trial judge’s denial upheld the jury’s determination that the plaintiffs hadn’t proven that Risperdal caused plaintiff’s medical issues.

To read the article, click here

Share Page On LinkedIn

Related Attorneys

John J. Sullivan


(212) 453-3729

Related Practices